ENVB - Enveric Biosciences, Inc. Forward P/S Multiple

Enveric Biosciences - graphic logo of issuer ENVB

Enveric Biosciences (ENVB) is currently in the early research stage of psychopharmacology without active profit generators. Geopolitical fragmentation limits the export of psychedelics and hinders global research. However, streamlined cross-border raw material logistics ensure high margins. The projected P/S metric reflects market revenue expectations, with the latest value recorded as .

ENVB enveric.com: Forward Price to Sales in the range 07/04/2022 - 11/13/2026

Summary analytical data breakdowns for Enveric Corp (ENVB)

- stock price and consensus target price:
Stock Quotes Enveric Biosciences, Inc.|ENVB - Price Target Chart
- market capitalization statistics:
Market Capitalization Enveric Corp|ENVB - Total Enterprise Value
- issuer book value statistics:
Net Assets per Single Share Enveric Biosciences|ENVB - Accounting Value of Company|Market Capitalization to Book Value Ratio enveric.com|ENVB - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Enveric Biosciences|ENVB - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Enveric Biosciences|ENVB - Aggregate Debt Obligations|Debts to Book Capitalization Enveric Corp|ENVB - Company Long-Term Debt|Company Short-Term Debts Enveric Biosciences|Quick Liquidity enveric.com
- business earnings and investment ratios data:
ENVB - Company Net Income|Expected Profit Enveric Biosciences|ENVB - Business Payback Period|Forward P/E Multiple Enveric|ENVB - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Enveric Corp|ENVB - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Enveric Biosciences|ENVB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months enveric.com|ENVB - Earnings per share growth this year|Earnings growth forecast for next year Enveric Biosciences
- company sales and revenue statistics:
ENVB - Company Sales|Projected Sales Volume Enveric Biosciences, Inc.|ENVB - Price to Sales|Price-to-Projected Revenue Ratio Enveric Corp
Summary company analysis:Enveric Biosciences, Inc. ENVB
Product sample of enveric.com

The forward P/S reflects market expectations regarding business value by comparing current capitalization with projected sales volume. Analyzing the forward P/S valuation at , an investor sees a premium for future growth, which for the non-cyclical biotech Enveric Biosciences (ENVB) depends not on macroeconomics, but on the volume of available cash and the success of clinical trials.

Who Enveric Biosciences competes with

Indivior - Forward Price-to-Revenue Multiple|Collegium Pharma - Price-to-Projected Revenue Ratio|Cronos - Forward P/S Multiple|Market Cap to Future Revenue Ratio Canopy Growth Corp.|High Tide Inc. (HITI) - Price-to-Projected Revenue Ratio|Aurora Cannabis Inc. - Forward Price to Sales|ACHV (Achieve Life Sciences, Inc.) - Forward P/S Multiple|Skye Bioscience Inc. (SKYE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ANEB|Forward Price-to-Revenue Multiple intercure.co INCR|Nutriband - Forward Price-to-Revenue Multiple|Forward Price to Sales NSRX|IGC Pharma Inc - Forward P/S Multiple|MIRA: Price-to-Projected Revenue Ratio|FLGC: Forward P/S Multiple|IMCC - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Adial Pharmaceuticals Inc.|Market Cap to Future Revenue Ratio Artelo ARTL|Price-to-Projected Revenue Ratio Ensysce Biosciences (ENSC)|Market Cap to Expected Sales Ratio titanpharm.com|Forward P/S Multiple GNLN (Greenlane Holdings Inc)|INM - Forward Price-to-Revenue Multiple|Akanda - Forward P/S Multiple|Market Cap to Expected Sales Ratio Bright Green BGXX|HPCO: Forward P/S Multiple